Cargando…
Forming next-generation antibody–nanoparticle conjugates through the oriented installation of non-engineered antibody fragments
The successful development of targeted nanotherapeutics is contingent upon the conjugation of therapeutic nanoparticles to target-specific ligands, with particular emphasis being placed on antibody-based ligands. Thus, new methods that enable the covalent and precise installation of targeting antibo...
Autores principales: | Greene, Michelle K., Richards, Daniel A., Nogueira, João C. F., Campbell, Katrina, Smyth, Peter, Fernández, Marcos, Scott, Christopher J., Chudasama, Vijay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869316/ https://www.ncbi.nlm.nih.gov/pubmed/29629076 http://dx.doi.org/10.1039/c7sc02747h |
Ejemplares similares
-
Cysteine-to-lysine transfer antibody fragment conjugation
por: Forte, Nafsika, et al.
Publicado: (2019) -
Enabling the controlled assembly of antibody conjugates with a loading of two modules without antibody engineering
por: Lee, Maximillian T. W., et al.
Publicado: (2017) -
Antibody fragments as nanoparticle targeting ligands: a step in the right direction
por: Richards, Daniel A., et al.
Publicado: (2017) -
Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates
por: Kim, Eunhee G., et al.
Publicado: (2020) -
Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging
por: Schumacher, Felix F., et al.
Publicado: (2014)